{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:15:05Z","timestamp":1784632505580,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:p>Although numerous studies have explored the connection between breast cancer surgery and sexual function, research on chemotherapy\u2019s temporal effects is limited. Addressing the impact of chemotherapy on sexual dysfunction is critical for improving quality of life. The aim of this study is to investigate changes in sexual function before, during, and after chemotherapy treatment, with a focus on associated factors. A total of 101 sexually active, reproductive-aged women diagnosed with locally advanced breast cancer were included in the study. The sexual dysfunction was evaluated by using the female sexual function index (FSFI) across 3 treatment phases: before, during, and after chemotherapy. Covariates such as age, baseline sexual dysfunction, tumor localization, comorbidity, family history of cancer, and receptor-related factors were analyzed for their influence on score changes during specific periods. A mixed-effects model was employed to evaluate associations and interactions between these variables and sexual function outcomes. Sexual function scores significantly declined across treatment phases. Notable reductions were observed in desire (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), arousal (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), lubrication (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), orgasm (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01), and satisfaction (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01), while pain scores increased (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01). Total FSFI scores significantly dropped during and after chemotherapy (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001 and <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01, respectively). Patients with preexisting sexual dysfunction experienced significantly greater declines in desire, lubrication, and satisfaction, along with more pronounced increases in pain-related discomfort scores, particularly in the FSFI pain subscale (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .01). Older age, comorbidity, and tumor localization were significantly associated with worsening sexual function, whereas receptor status and histopathology showed no meaningful effect. Our findings confirm a high prevalence of sexual dysfunction among women with breast cancer. These results highlight the multifaceted impact of chemotherapy on sexual function and reveal a clear temporal pattern of changes across treatment phases.<\/jats:p>","DOI":"10.1097\/md.0000000000043516","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:00:28Z","timestamp":1753156828000},"page":"e43516","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of chemotherapy on sexual dysfunction in Turkish women with breast cancer: A single-center prospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-8482","authenticated-orcid":false,"given":"Ruhper","family":"\u00c7ekin","sequence":"first","affiliation":[{"name":"Department of Oncology, Okan University Hospital, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didar","family":"\u015eenocak","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Health Sciences, Sultan Abdulhamid Khan Training and Research Hospital, Istanbul, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Arici","sequence":"additional","affiliation":[{"name":"Department of Oncology, Okan University Hospital, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.3390\/cancers14174218","article-title":"Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives.","volume":"14","author":"Lim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"17455057241237687","DOI":"10.1177\/17455057241237687","article-title":"Care for breast cancer survivors in Asian countries: a review of sexual dysfunction.","volume":"20","author":"Jehan","year":"2024","journal-title":"Womens Health (Lond)"},{"key":"R4-20250722","first-page":"726","article-title":"Management of breast cancer therapy-related sexual dysfunction.","volume":"31","author":"Taylor","year":"2017","journal-title":"Oncology (Williston Park)"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cps.2022.06.009","article-title":"Female sexual dysfunction.","volume":"49","author":"Reed","year":"2022","journal-title":"Clin Plast Surg"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"100351","DOI":"10.1016\/j.esxm.2021.100351","article-title":"Sexual dysfunction among women with breast cancer in the Northeastern part of West Malaysia.","volume":"9","author":"Ooi","year":"2021","journal-title":"Sex Med"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.maturitas.2010.03.027","article-title":"Sexuality after breast cancer: a review.","volume":"66","author":"Emilee","year":"2010","journal-title":"Maturitas"},{"key":"R8-20250722","first-page":"264","article-title":"Effects of surgery type on body image, sexuality, self-esteem, and marital adjustment in breast cancer: a controlled study.","volume":"15","author":"Onen Sert\u00f6z","year":"2004","journal-title":"Turk Psikiyatri Derg"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jjns.12106","article-title":"Assessing sexual function and dysfunction in Turkish women undergoing surgical breast cancer treatment.","volume":"13","author":"\u00d6zt\u00fcrk","year":"2016","journal-title":"Jpn J Nurs Sci"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/jwh.1.1999.8.949","article-title":"The risk of premature menopause induced by chemotherapy for early breast cancer.","volume":"8","author":"Lower","year":"1999","journal-title":"J Womens Health Gend Based Med"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1016\/j.esxm.2016.02.004","article-title":"The relationship between body image and domains of sexual functioning among heterosexual, emerging adult women.","volume":"4","author":"Quinn-Nilas","year":"2016","journal-title":"Sex Med"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.breast.2014.06.012","article-title":"Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study.","volume":"23","author":"Aerts","year":"2014","journal-title":"Breast"},{"key":"R13-20250722","article-title":"Breast cancer research."},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"418","DOI":"10.15386\/mpr-2458","article-title":"Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy.","volume":"95","author":"Papadopoulou","year":"2022","journal-title":"Med Pharm Rep"},{"key":"R15-20250722","first-page":"2499","article-title":"Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy.","volume":"21","author":"Park","year":"2013","journal-title":"Support Care Cancer"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2407-14-228","article-title":"Feeling well and talking about sex: psycho-social predictors of sexual functioning after cancer.","volume":"14","author":"Perz","year":"2014","journal-title":"BMC Cancer"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.fertnstert.2009.07.1173","article-title":"The female sexual function index (FSFI): a potential \u201cgold standard\u201d measure for assessing therapeutically-induced change in female sexual function.","volume":"92","author":"Sand","year":"2009","journal-title":"Fertil Steril"},{"key":"R19-20250722","first-page":"393","article-title":"The Turkish adaptation of the female sexual function index.","volume":"25","author":"Aygin","year":"2005","journal-title":"Turk Klin J Med Sci"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.3390\/ijerph191911921","article-title":"Sexual dysfunction in women with cancer: a systematic review of longitudinal studies.","volume":"19","author":"Sousa Rodrigues Guedes","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1472-6874-12-28","article-title":"Sexual function and chemotherapy in postmenopausal women with breast cancer.","volume":"12","author":"Cavalheiro","year":"2012","journal-title":"BMC Womens Health"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"111322","DOI":"10.1016\/j.mce.2021.111322","article-title":"Mechanisms of endocrine therapy resistance in breast cancer.","volume":"532","author":"Rasha","year":"2021","journal-title":"Mol Cell Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:00:30Z","timestamp":1753156830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":21,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043516","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}